v3.24.4
Earnings Per Share (Q3) (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]    
Schedule of Antidilutive Shares
The following table summarizes potential common shares that were excluded as their effect is anti-dilutive:

 
 
 
 
 
 
 
 
 
 
Three Months Ended
September 30,
 
 
Nine Months Ended
September 30,
 
 
 
2024
 
 
2023
 
 
2024
 
 
2023
Options and unvested stock units outstanding
 
 
106,097
 
 
296,861
 
 
145,073
 
 
235,736
Warrants outstanding
 
 
30,017,768
 
 
629,271
 
 
30,017,768
 
 
629,271
Convertible promissory notes
 
 
4,339,623
 
 
—
 
 
4,339,623
 
 
—
Contingent Sponsor Earnout Shares
 
 
28,750
 
 
28,750
 
 
28,750
 
 
28,750
Total
 
 
34,492,238
 
 
954,882
 
 
34,531,214
 
 
893,757
 
 
 
 
 
 
 
 
 
 
 
 
 
The following table summarizes potential common shares that were excluded as their effect is anti-dilutive:

 
 
 
 
 
 
 
Year Ended December 31,
 
 
 
2023
 
 
2022
Options and unvested stock units outstanding
 
 
243,911
 
 
127,116
Warrants outstanding
 
 
6,206,488
 
 
399,149
Contingent Sponsor Earnout Shares
 
 
28,750
 
 
28,750
Total
 
 
6,479,149
 
 
555,015